Linear endoscopic ultrasound for clinically suspected bile duct stones  by Lin, Lien-Fu & Huang, Pi-Teh
Available online at www.sciencedirect.comJournal of the Chinese Medical Association 75 (2012) 251e254
www.jcma-online.comOriginal Article
Linear endoscopic ultrasound for clinically suspected bile duct stones
Lien-Fu Lin*, Pi-Teh Huang
Division of Gastroenterology, Department of Internal Medicine, Tungs’ Taichung Metroharbor Hospital, Taichung, Taiwan, ROC
Received November 9, 2011; accepted February 3, 2012AbstractBackground: Radial endoscopic ultrasound (EUS) is a less invasive imaging modality used to evaluate common bile duct stones (CBDS) and is
as accurate as endoscopic retrograde cholangiography (ERCP). Patients classified as high risk for suspected CBDS were found to have stones in
only two-thirds of cases, and an argument could be made for performing EUS in these high-risk patients. There are very few reports of linear
EUS for CBDS detection. Our aim was to evaluate the diagnostic efficiency of linear EUS in patients with suspected CBDS in intermediate- and
high-risk groups.
Methods: This is a retrospective analysis of prospectively collected data for 30 patients with suspected CBDS assessed using linear EUS. The
inclusion criteria were acute epigastric pain, abnormal liver function test (LFT), and CBDS not detected by transabdominal ultrasound or
computed tomography. The exclusion criteria were failure to insert a linear EUS endoscope into the duodenum and Billroth II gastrectomy.
ERCP was performed in patients with positive CBDS on linear EUS. Cases with negative CBDS after linear EUS examination were followed in
terms of clinical symptoms and LFT for at least for 3 months as outpatients.
Results: There were 17 male and 13 female patients with a mean age of 53 (17.6) years. Twelve cases were positive for CBDS, of which 11
were confirmed by ERCP and one was a false positive. In cases with negative CBDS on linear EUS, the median follow-up duration was 9 (3e12)
months. The overall sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were 100%, 94.7%, 91.7%, 100%,
and 96.7%, respectively. CBDS was positive in 56% (9/16) of high-risk patients and 14.3% (2/14) of intermediate-risk patients.
Conclusion: Linear EUS is sensitive for the detection of CBDS. It detected 56% of CBDS in a high-risk group and 14.2% in an intermediate-risk
group and therefore is a useful assessment tool in patients with high or intermediate risk of CBDS.
Copyright  2012 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Conventional endoscopic retrograde cholangiopancreatog-
raphy (ERCP) is supposed to be the gold standard for detection
of common bile duct stones (CBDS) but it can yield negative
results in 38e80% of cases with unconfirmed CBDS.1,2
Furthermore, ERCP carries a risk of pancreatitis of up to
2%. EUS is a less invasive imaging modality for evaluation of
CBDS with accuracy comparable to that of ERCP.3 Patients
classified as high risk of suspected CBDS were found to have
stones in only two-thirds of cases.4,5 It is reasonable to* Corresponding author. Dr. Lien-Fu Lin, 8, 11th Floor, Mei Tsun Road,
Section 2, Lane 168, Taichung 402, Taiwan, ROC.
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doi:10.1016/j.jcma.2012.04.006perform EUS in all clinically suspected unconfirmed cases of
CBDS. Most of the reports in the literature focused on radial
EUS, with few reports involving linear EUS for CBDS.6 We
report our experience of linear EUS for clinically suspected
CBDS where stones were not detected by prior transabdominal
ultrasonography (TAU) or computed tomography (CT)
imaging.
2. Methods
This is a retrospective analysis of prospectively collected
data. From December 2009 to June 2011, a total of 30 patients
with suspected CBDS were enrolled for a linear EUS study.
The inclusion criteria were: (1) acute upper abdominal pain
and abnormal liver function test (with or without fever, withhinese Medical Association. All rights reserved.
Fig. 1. Common bile duct stones detected by linear endoscopic ultrasound in (A) the stomach, (B) the duodenal bulb and (C) the descending duodenum.
Fig. 2. (A) Common bile duct stone detected in the stomach and confirmed by (B) endoscopic sphincterotomy and (C) stone extraction.
252 L.-F. Lin, P.-T. Huang / Journal of the Chinese Medical Association 75 (2012) 251e254gall bladder (GB) in situ or post-cholecystectomy, with or
without biliary dilation); and (2) CBDS not detected by TAU
or CT. The exclusion criteria were: (1) a linear EUS endoscopeFig. 3. (A) Echogenic lesion mistaken for a common bile duct stone. (B) Malign
(ERCP). (C) Low-density lesion of the gall bladder demonstrated by compute
(E) Endoscopic transpapillary biopsy during ERCP. (F) A moderately differentiatecould not be inserted into the duodenum; and (2) Billroth II
gastrectomy. Negative CBDS on linear EUS was defined as no
CBDS found on linear EUS, relief of biliary colic,ant common hepatic duct stricture on endoscopic retrograde cholangiography
d tomography. (D) Endoscopic retrograde brushing cytology during ERCP.
d adenocarcinoma was found.
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period of at least 3 months. An abnormal LFT was defined
as elevation of aspartate transaminase, alanine transaminase,
bilirubin, and r-glutamine transpeptidase (rGT) above normal
upper limits. Suspected CBDS was classified as high or
intermediate risk according to standard guidelines,7 but
without CBDS detected in TAU or CT images. High-risk
predictors according to the guidelines include CBDS
observed by TAU or clinical ascending cholangitis or bilirubin
>4 mg/dL or both dilated CBD on TAU and bilirubin of
1.8e4 mg/dL.7 Patients with abnormal LFT other than bili-
rubin, or >55 years of age or with clinical gallstone pancre-
atitis were classified as intermediate risk. After written
informed consent was obtained, conscious sedation (demerol,
midazolam) was administered to the patient and EKG, blood
pressure, and pulse oximetry were monitored during linear
EUS (GF-UCT2000, EUC2000 unit, Olympus, Tokyo, Japan)
of the stomach, duodenal bulb, and descending duodenum
(Fig. 1AeC). In cases with positive CBDS, ERCP or endo-
scopic sphincterotomy (EST) was performed (Fig. 2AeC). For
patients who tested negative for CBDS on linear EUS, LFT
was performed on the second and fourth days, and then fol-
lowed for at least for 3 months (at OPD or by phone).-CBDS: common bile duct stone  
-ERCP: endoscopic retrograde cholangio-pancreaticogra
-ETPB: endoscopic transpapillary biopsy CT: computeri
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Chart3. Results
The results are shown in Chart 1. There were 17 male and
13 female patients with a mean age of 53 (17.6) years.
Sixteen cases were classified as high risk for CBDS (3 had
mild intra-hepatic duct dilation) and 14 as intermediate risk.
Linear EUS detected CBDS in 12 cases (10 in the high-risk
group, 2 in the intermediate-risk group). EST was performed
in 10 cases and one case underwent surgery because of
multiple large CBDS. The false-positive CBDS was a case of
GB neck cancer with invasion of the common hepatic duct
(CHD). The echogenic lesion was mistaken for a stone
(Fig. 3A), but ERC revealed a malignant CHD stricture
(Fig. 3B), CT showed low density in the GB region (Fig. 3C),
and histological analysis using endoscopic retrograde brush
cytology and a transpapillary biopsy revealed adenocarcinoma
(Fig. 3DeF). Together, these findings led to a pre-operative
diagnosis of GB cancer with invasion of the CHD. Among
18 cases of negative EUS findings for CBDS, one had an intra-
operative cholangiogram performed during laparoscopic
cholecystectomy. The median follow-up duration for the
remaining 17 cases was 9 months (range 3e12). In these 17
cases, 15 had no biliary colic, no biliary dilation, and normalm EST: endoscopic sphincterotomy 
zed tomography Op:operation 
 cholangiogram  
an age 53 years
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alcohol with no CBDS observed on a second EUS examina-
tion, and the remaining case had mild elevation of rGT due to
consumption of herbs. The overall sensitivity, specificity,
positive predictive value, negative predictive value, and
accuracy were 100%, 94.7%, 91.7%, 100%, and 96.7%,
respectively. CBDS was positive in 56% (9/16) of the high-risk
patients, with one false-positive case, and 14.3% (2/14) of the
intermediate-risk patients.
4. Discussion
EUS is relatively non-invasive compared with ERCP but
has high accuracy in predicting CBDS. In a meta-analysis of
radial EUS, the overall pooled sensitivity was 0.94 (95% CI
0.93e0.96) and the specificity was 0.95 (95% CI 0.94e0.96),
with an area under the curve of 0.98.3 However, very few
linear EUS studies to assess CBDS have been reported.8e10 In
our series, sensitivity, specificity, positive predictive value,
negative predictive value, and accuracy for CBDS detection
were 100%, 94.7%, 91.7%, 100%, and 96.7%, respectively.
We had one false-positive case mistaken for CBDS, which was
later identified as GB cancer with invasion of the common
hepatic duct by ERCP and trans-papillary brushing cytology
and biopsy. A review of the images indicates that the echo-
genic lesion (Fig. 3A) could be sludge or a tumor in the bile
duct. Lachter et al reported four false positives out of 50 cases
using linear EUS,8 but higher specificity of 93% was reported
by Kohut et al.9
We found a CBDS-positive rate of 56% in the high-risk
group and 14.3% in the intermediate-risk group. According
to the literature, the CBDS-positive rate ranges from 10% to
50% in intermediate-risk groups and is greater than 50% in
high-risk groups.7 We saved 44% of our high-risk and 85.7%
of our intermediate-risk patients an ERCP procedure.
According to guidelines,7 ERCP is recommended for high-risk
patients, but CBDS observed by TAU is included in the criteria
for high-risk patients. We excluded patients with CBDS
observed by TAU or CT from our high-risk group, and
therefore EUS was worthwhile for the high-risk group in our
series.We did not use ERCP as a confirmation test for negative
CBDS on linear EUS. Kohut et al did not use ERCP either, but
their clinical follow-up for negative CBDS on linear EUS was
of longer duration.10 The limitation of our study is the shorter
follow-up period in some cases of negative CBDS, although
the median follow-up duration was 9 months.
In conclusion, linear EUS should be considered sensitive
for the detection of CBDS and can be useful in intermediate-
and high-risk patients when CBDS is not detected by prior
TAU or abdominal CT imaging.References
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